ProVen VCT, managed by Beringea, has a strong track record of lead investments and focuses on industries such as healthcare and financial services. It typically invests in startups that are 6-10 years old and has a portfolio of successful companies including BioVex, Abzena plc, and Altacor. The fund is actively involved in less than 2 deals per year and has a higher rate of exits compared to other organizations.